Blogs Exploring Business Opportunities in India: Insights from Foley & Lardner’s General Counsel Series In today's globalized world, understanding international markets is crucial for businesses aiming to expand their…Louis LehotMarch 14, 2024
Blogs Strategies for the Tech Sector in 2024 After two very difficult years in the tech sector, everyone is hoping for a comeback.…Louis LehotMarch 12, 2024
Blogs A Look at VC Investment in the Gaming Sector Gaming was once seen as a niche enjoyed by a small portion of the population,…Lyman ThaiMarch 5, 2024
News Louis Lehot Speaks on 2024 Venture Capital Trends at the FOA Global Impact Forum Foley & Lardner LLP partner Louis Lehot moderated a panel on February 29, 2024, at…Louis LehotMarch 1, 2024
News Foley Represents TCGX as Lead Investor in $127.5M Private Placement for Adverum Biotechnologies Foley & Larder LLP represented TCG Crossover (“TCGX”) as the lead investor in the $127.5…Louis LehotFebruary 13, 2024
News Foley Represents TCGX as Investor in $120M Private Placement for Silence Therapeutics Foley & Larder LLP represented TCG Crossover (“TCGX”) as an investor in the $120 million…Louis LehotFebruary 13, 2024
News Foley Represents TCGX as Lead Investor in $120M Private Financing for Mineralys Therapeutics Foley & Larder LLP recently represented TCG Crossover (“TCGX”) as a lead investor in the…Louis LehotFebruary 13, 2024
Blogs What to Expect for Venture Capital in 2024: Looking Backward at 2023 to Inform How to Look Forward to 2024 Most startup founders will tell you that securing funding in 2023 was challenging, to say…Louis LehotJanuary 26, 2024
News Foley Represents TCGX as Investor in Tourmaline Bio, Concurrent with Merger with Talaris Therapeutics Foley & Lardner LLP represented TCGX as an investor in the $75 million private placement…Louis LehotJanuary 24, 2024
News Louis Lehot Offers Insight on Corporate M&A Momentum for 2024 Foley & Lardner LLP partner Louis Lehot is quoted in the Middle Market Growth article, “Corporate M&A…Louis LehotJanuary 24, 2024